Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Bilateral Vision Loss Responsive to Corticosteroids.
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Interplaying factors that effect multiple sclerosis causation and sustenance.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
Early recognition and diagnosis of multiple sclerosis.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Mimics and chameleons of optic neuritis.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
The axes of access--improving care for patients with disabilities.
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis.
[Vitamin D tweets light to genes in multiple sclerosis].
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Pages